Antioxidant, Anti-inflammatory and Neuroprotective Profiles of Novel 1,4-Dihydropyridine Derivatives for the Treatment of Alzheimer’s Disease

• Main Authors: Patrycja Michalska, Paloma Mayo, Cristina Fernández-Mendívil, Giammarco Tenti, Pablo Duarte, Izaskun Buendia, María Teresa Ramos, Manuela G. López, J. Carlos Menéndez, Rafael León
• Format: Article
• Language: English
• Published: MDPI AG 2020-07-01
• Series: Antioxidants
• Subjects: Alzheimer’s disease; multitarget drugs; 4,7-dihydro-2<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridines GSK‑3β inhibitors; voltage gated calcium channels antagonists; anti-inflammatory drugs; neuroprotection
• Online Access: https://www.mdpi.com/2076-3921/9/8/650

Alzheimer’s disease is a chronic and irreversible pathological process that has become the most prevalent neurodegenerative disease. Currently, it is considered a multifactorial disease where oxidative stress and chronic neuroinflammation play a crucial role in its onset and development. Its characteristic neuronal loss has been related to the formation of neurofibrillary tangles mainly composed by hyperphosphorylated tau protein. Hyperphosphorylation of tau protein is related to the over-activity of GSK-3β, a kinase that participates in several pathological mechanisms including neuroinflammation. Neuronal loss is also related to cytosolic Ca²⁺ homeostasis dysregulation that triggers apoptosis and free radicals production, contributing to oxidative damage and, finally, neuronal death. Under these premises, we have obtained a new family of 4,7-dihydro-2<i>H</i>-pyrazolo[3–<i>b</i>]pyridines as multitarget directed ligands showing potent antioxidant properties and able to scavenge both oxygen and nitrogen radical species, and also, with anti-inflammatory properties. Further characterization has demonstrated their capacity to inhibit GSK-3β and to block L-type voltage dependent calcium channels. Novel derivatives have also demonstrated an interesting neuroprotective profile on in vitro models of neurodegeneration. Finally, compound <b>4g</b> revokes cellular death induced by tau hyperphosphorylation in hippocampal slices by blocking reactive oxygen species (ROS) production. In conclusion, the multitarget profile exhibited by these compounds is a novel therapeutic strategy of potential interest in the search of novel treatments for Alzheimer’s disease.